Current position

Terry Smith’s Procter & Gamble (PG) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Fundsmith LLPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2013Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares4.85MHighest verified quarter-end share count
Quarters reported33Verified quarters with shares above zero
What happened?

Fundsmith LLP first reported Procter & Gamble in Q3 2013. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Fundsmith LLP currently reports 4.08M shares. The latest verified filing showed: Sold 2.9% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 2.9% of the position−121.54K shares · 4.08M shares remained
Filing context

Quarter-end price $146.64 · Estimated holding basis $150.08

Q1 2026
Sold 1.1% of the position−48.13K shares · 4.20M shares remained
Filing context

Quarter-end price $144.44 · Estimated holding basis $150.08

Q4 2025
Sold 7.2% of the position−328.99K shares · 4.25M shares remained
Filing context

Quarter-end price $143.31 · Estimated holding basis $150.08

Q3 2025
Bought 0.1% more+4.76K shares · 4.58M shares reported after the change
Filing context

Quarter-end price $153.65 · Estimated holding basis $150.08

Q2 2025
Sold 1.0% of the position−48.13K shares · 4.57M shares remained
Filing context

Quarter-end price $159.32 · Estimated holding basis $150.08

Q1 2025
Sold 0.1% of the position−5.97K shares · 4.62M shares remained
Filing context

Quarter-end price $170.42 · Estimated holding basis $150.08

3 unchanged quarters are collapsed by default.

Portfolio importance

How important is Procter & Gamble in Fundsmith LLP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight4.4%Q2 2026
Current rank#9of 41 reported positions
Peak portfolio weight6.6%Q4 2013
Best historical rank#8Q3 2013
At peak importanceQ4 2013
PG
6.6%
Largest holding
9.9%
Cross-investor discovery

Who else owns Procter & Gamble?

Also reported by 3 other tracked investors in their latest verified filings.

Ray DalioBridgewater Associates, LP
PG0.1% of reported portfolio
Joel GreenblattGotham Asset Management
PG0.1% of reported portfolio
Tom RussoGardner Russo & Quinn · formerly Gardner Russo & Gardner
PG0.0% of reported portfolio
Explore Procter & Gamble across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$146.392026-09-18

Market context only; not an investor transaction price.

Latest filing quarter-end price$146.64Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$150.08Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

View Procter & Gamble stock page →

This tracker follows Fundsmith LLP’s reported positions. Form 13F reports quarter-end positions and is filed later; it does not disclose exact trade dates or execution prices.